Light Mode
$115.71 ↑ +0.00 (+0.00%) Trading Up from the previous close of $115.71, $1.16 below the day’s high of $116.87
+21.06 (+22.25%) / 6M
Momentum, market sentiment, and recent alerts
INCY reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +26.8%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.